Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Summaries for patients. Does measuring genetic variations at chromosome 9p21.3 help to predict cardiovascular disease in women?

[No authors listed]

Ann Intern Med. 2009 Jan 20;150(2):I-36. No abstract available.

PMID:
19153408
2.

Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.

Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM.

Ann Intern Med. 2009 Jan 20;150(2):65-72.

3.

Questions about genetic variation in 9p21 as a predictor of cardiovascular risk.

Gulcher J, Stefansson K.

Ann Intern Med. 2009 May 19;150(10):736; author reply 737. No abstract available.

PMID:
19451588
4.

Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study.

Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S.

J Am Coll Cardiol. 2008 Jul 29;52(5):378-84. doi: 10.1016/j.jacc.2007.11.087.

5.

Questions about genetic variation in 9p21 as a predictor of cardiovascular risk.

Kiljanek L.

Ann Intern Med. 2009 May 19;150(10):736; author reply 737. No abstract available.

PMID:
19451587
6.

Chromosome 9p21 and cardiovascular disease: the story unfolds.

Samani NJ, Schunkert H.

Circ Cardiovasc Genet. 2008 Dec;1(2):81-4. doi: 10.1161/CIRCGENETICS.108.832527. No abstract available.

7.

Chromosome 9p21 genetic variation explains 13% of cardiovascular disease incidence but does not improve risk prediction.

Gränsbo K, Almgren P, Sjögren M, Smith JG, Engström G, Hedblad B, Melander O.

J Intern Med. 2013 Sep;274(3):233-40. doi: 10.1111/joim.12063. Epub 2013 Mar 25.

8.

Questions about genetic variation in 9p21 as a predictor of cardiovascular risk.

Schwarzenbach JR.

Ann Intern Med. 2009 May 19;150(10):736; author reply 737. No abstract available.

PMID:
19451586
9.

A common variant in chromosome 9p21 associated with coronary artery disease in Asian Indians.

Maitra A, Dash D, John S, Sannappa PR, Das AP, Shanker J, Rao VS, Sridhara H, Kakkar VV.

J Genet. 2009 Apr;88(1):113-8. No abstract available.

PMID:
19417554
10.

The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.

Chen SN, Ballantyne CM, Gotto AM Jr, Marian AJ.

BMC Cardiovasc Disord. 2009 Jan 27;9:3. doi: 10.1186/1471-2261-9-3.

11.

Gaining insights in coronary disease genomics.

Murray SS, Topol EJ.

J Am Coll Cardiol. 2008 Jul 29;52(5):385-6. doi: 10.1016/j.jacc.2008.04.032. No abstract available.

12.

Translating genetic discoveries to improvements in cardiovascular care: the path to personalized medicine.

Hall JL.

J Cardiovasc Transl Res. 2008 Mar;1(1):37-40. doi: 10.1007/s12265-008-9010-8. Epub 2008 Feb 8. Review.

PMID:
20559956
13.

Genes, diabetes and cardiovascular risk prediction.

Del Prato S.

Nat Rev Endocrinol. 2009 Apr;5(4):192-3. doi: 10.1038/nrendo.2009.47.

PMID:
19352316
14.

Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.

Tousoulis D, Briasoulis A, Papageorgiou N, Antoniades C, Stefanadis C.

Trends Mol Med. 2008 Oct;14(10):441-9. doi: 10.1016/j.molmed.2008.08.004. Epub 2008 Sep 9. Review.

PMID:
18786860
15.

Interleukin-18 and cardiovascular events.

Marian AJ.

Curr Atheroscler Rep. 2006 May;8(3):173-4. No abstract available.

PMID:
16767839
16.

The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.

Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O.

J Hypertens. 2009 Apr;27(4):769-73. doi: 10.1097/HJH.0b013e328326f7eb.

PMID:
19293724
17.

Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors.

Wiedmann S, Neureuther K, Stark K, Reinhard W, Kallmünzer B, Baessler A, Fischer M, Linsel-Nitschke P, Erdmann J, Schunkert H, Hengstenberg C.

Obesity (Silver Spring). 2009 Jul;17(7):1390-5. doi: 10.1038/oby.2008.669. Epub 2009 Feb 5.

18.

Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease.

Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, Jessurun GA, Tio RA.

Am J Med. 2004 Mar 15;116(6):429-30. No abstract available.

PMID:
15006595
19.

Health and mortality consequences of abdominal obesity: evidence from the AusDiab study.

Cameron AJ, Dunstan DW, Owen N, Zimmet PZ, Barr EL, Tonkin AM, Magliano DJ, Murray SG, Welborn TA, Shaw JE.

Med J Aust. 2009 Aug 17;191(4):202-8.

PMID:
19705980
20.

Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.

Kaur-Knudsen D, Bojesen SE, Nordestgaard BG.

Pharmacogenomics J. 2009 Oct;9(5):327-32. doi: 10.1038/tpj.2009.34. Epub 2009 Aug 4.

PMID:
19652664
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk